All partnering requests
OTC pain-relief digital tools, delivery methods, and formulations
  • Background
  • What we're looking for
  • What we can offer you
  • Who we are
  • Q&A
Have questions about this request?
Get them answered by the team at Haleon.
Background

Young children (2 – 12 yrs) frequently experience pain from teething, minor injuries, mild fever, post-vaccination soreness, headaches, rhinitis-related ENT discomfort, persistent cough and other common ailments. Caregivers typically rely on over the counter (OTC) analgesics (acetaminophen, ibuprofen) whose adult-derived formats pose challenges: bitter taste, swallowing difficulty, dosing errors, and parental anxiety over repeat administration or long-term safety. 

 

Growing consumer interest in non-drug or low-dose approaches (wearables, neuro-stimulation, botanical actives, psychological techniques) adds complexity: products must be evidence-based and easy to adopt, yet still affordable and widely accessible. A new generation of child-centric pain-relief solutions—combining formulation science, digital health and human-factors design—can close this gap.

What we're looking for

We are looking for innovative, scalable technologies (pharmaceutical, non-pharmacological or hybrid) that deliver safe, effective, and caregiver-friendly pain relief tailored specifically to children. Solutions should be available over the counter (OTC) and improve one or more of: dosing precision, onset time, palatability/acceptance, convenience, safety profile, or caregiver guidance.

Solutions of interest include:
  • Palatable, low-dose oral formats (e.g., quick-dissolve films, melt-in-mouth tablets, gummies)
  • Needle-free transdermal or intranasal delivery systems enabling rapid onset
  • Connected “smart-cap” or app-paired dispensers
  • Wearable neurostimulation / TENS or thermal devices
  • Evidence-based botanical or biomaterial actives (GRAS or equivalent)
  • Multimodal combinations (analgesic + antihistamine, analgesic + mild sedative)
  • Sensor-integrated patches or bandages that deliver actives and monitor skin
  • Lollipop style delivery enabling both soothing and precise micro-dosing of actives
  • AI-driven caregiver apps that integrate symptom tracking, dose logs, and HCP escalation triggers
  • Gamified VR/AR or biofeedback tools that distract and coach children through acute pain episodes
Our must-have requirements are:
  • Demonstrated or strongly reasoned pediatric safety
  • Path to achieving rapid onset of relief (<10 min) and duration ≥ 6 h
  • Acceptable sensory profile for ages 2 – 12 (pleasant taste/texture, non-intimidating form factor)
Our nice-to-have's are:
  • Manufacturable at a commercial scale
What's out of scope:
  • Opioid-containing, prescription-only, or injectable solutions
  • Adult formulations repackaged for kids without addressing taste, dose accuracy, or safety
  • Highly invasive devices (e.g., implantables) or technologies requiring continuous health care provider supervision
Acceptable technology readiness levels (TRL):
Levels 4-9
What we can offer you
Eligible partnership models:
Sponsored researchCo-developmentSupply/purchaseLicensing
Benefits:
Sponsored Research
Funding is proposal-dependent, starting with a proof-of-concept project that has the potential for expansion based on results and opportunities. The funding range is typically from $25,000 to $100,000 for a six-month project.
Expertise
We also offer the expertise of our team of scientists for collaboration and guidance during the project’s development. Possible partnerships with us include, but are not limited to, sponsored research, joint development, supply, consulting, and licensing.
Who we are

Our global team is dedicated to developing and collaborating on future-facing, scientifically proven, consumer-focused innovations and technologies. We believe that true innovation comes from collaboration and partnerships with start-ups, academia, health tech pioneers, and innovators.

Haleon has a strong portfolio of consumer health brands and plays a vital role for people all around the world, in a sector that is growing and more relevant than ever. We have five brand categories: Oral Health, Vitamins, Minerals and Supplements(VMS), Pain, Respiratory & Digestive. Our trusted brands like Sensodyne, Advil, Centrum & Voltaren improve the lives of millions globally.

 Learn more
Reviewers
Q&A with Haleon

The Q&A is now closed.

Sort by:
Q.
Can a proposal focused on pediatric melt-in-mouth tablets made by direct compression, without smart dispensers or advanced sensory design, meet your needs if it improves dosing precision, onset time, and scalability?
1
A.
Dear Carlos, thank you for your comment. Indeed, novel delivery methods, such as melt-in-mouth tablets, that would improve dosing, speed and/or scalability would be definitely in scope. I would recommend going ahead and submitting your proposal with some preliminary details about your project. Once the submission period closes, we’ll review all entries together with the internal team. Thanks again for your interest—we’re looking forward to learning more about your idea!
MG
Matteo Gasbarri, External Innovation Senior Scientist, Haleon
June 18, 2025
Is this response helpful?
0
0
Q.
Hello, would this RFP be appropriate for a multisite feasibility study of a newly designed virtual reality intervention for pediatric patients with Sickle Cell Disease in acute pain episodes?
1
A.
Dear Deirde, thank you for your interest in the RFP. We are looking for holistic approach to pain, therefore if your approach could be extended to generic pain episode (beyond just Sickle Cell Disease), our team would be happy to review it. I would recommend going ahead and submitting your proposal with some preliminary details about your project. Once the submission period closes, we’ll review all entries together with our experts. Thanks again for your interest—we’re looking forward to learning more about your idea!
MG
Matteo Gasbarri, External Innovation Senior Scientist, Haleon
July 22, 2025
Is this response helpful?
0
0
Sign up to access the full partnering request.
View the details of this request and connect directly with corporate R&D teams at Fortune 500 companies.
Share partnering request
Complete
Refine recommendations
Is this request relevant to you?
Eligible partners
Academic researchersStartupsSuppliers
Seeking partners focused on
AnatomyAllergiesArtificial IntelligenceBiochemistryBiological ComplexityBiological Fluid DynamicsBiomimeticsBiomolecular ProcessesBiopharmaceuticsBotany
54 more

Halo home
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.